Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study

Abstract

BackgroundThe HIV epidemic in Russia is concentrated among injection drug users (IDUs). This is especially true for St. Petersburg where high HIV incidence persists among the city’s estimated 80,000 IDUs. Although sterile syringes are legally available, access for IDUs may be hampered. To explore the feasibility of using pharmacies to expand syringe access and provide other prevention services to IDUs, we investigated the current access to sterile syringes at the pharmacies and the correlation between pharmacy density and HIV prevalence in St. Petersburg.Methods965 pharmacies citywide were mapped, classified by ownership type, and the association between pharmacy density and HIV prevalence at the district level was tested. We selected two districts among the 18 districts – one central and one peripheral – that represented two major types of city districts and contacted all operating pharmacies by phone to inquire if they stocked syringes and obtained details about their stock. Qualitative interviews with 26 IDUs provided data regarding syringe access in pharmacies and were used to formulate hypotheses for the pharmacy syringe purchase test wherein research staff attempted to purchase syringes in all pharmacies in the two districts.ResultsNo correlation was found between the density of pharmacies and HIV prevalence at the district level. Of 108 operating pharmacies, 38 (35%) did not sell syringes of the types used by IDUs; of these, half stocked but refused to sell syringes to research staff, and the other half did not stock syringes at all. Overall 70 (65%) of the pharmacies did sell syringes; of these, 49 pharmacies sold single syringes without any restrictions and 21 offered packages of ten.ConclusionsTrainings for pharmacists need to be conducted to reduce negative attitudes towards IDUs and increase pharmacists’ willingness to sell syringes. At a structural level, access to safe injection supplies for IDUs could be increased by including syringes in the federal list of mandatory medical products sold by pharmacies.

Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs

“…In Russia, there is no opioid agonist treatment, little access to overdose prevention education and naloxone rescue kits, and inadequate availability of clean needles and syringes in the community (Mathers et al 2010, Degenhardt et al 2014, Federova et al 2013). A qualitative study among PWID in St. Petersburg found knowledge about overdose, experiencing overdose, and witnessing overdose are common, but PWIDs do not feel empowered to prevent or address overdose death (Grau et al 2009).…”

Correlates of Lifetime History of Purchasing Sex Services by Men in Saint Petersburg and Leningrad Oblast, Russia

“… 1 – 3 Injection drug use has been a major driver since the beginning of the HIV epidemic in the Russian Federation, 4 but during recent years, a major route of HIV transmission has been sexual transmission. 5 – 7 According to the official statistics from the Federal AIDS Center of Russian Federation, 42 % of 79,728 people diagnosed with HIV in 2013 were infected through heterosexual sex. 8…”

Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon

“…As revealed in previous research, pharmacists feared disease spread, increased drug use and inappropriately discarded syringes as a result of easier syringe access and were concerned about staff and customer safety (Coffin, Linas, Factor, & Vlahov, 2000;Davidson et al, 2012;Deibert et al, 2006). They had negative attitudes towards IDU and prominent concerns regarding stereotypical drug user behavior (theft and aggression) that threatens their business (Fedorova et al, 2013;Lewis, Koester, & Bush, 2002). IDU attempted to purchase only at acquaintance pharmacies and were concerned with improving their physical appearance to favor pharmacists' decision to sell syringes Pollini et al, 2010).…”